Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 2:13:881063.
doi: 10.3389/fphar.2022.881063. eCollection 2022.

Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study

Affiliations

Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study

Haiyan Li et al. Front Pharmacol. .

Abstract

Background: Stress ulcer prophylaxis (SUP) prescribed in patients admitted to surgical wards with a low risk of stress-related mucosal disease (SRMD) accounted for a considerable proportion of improper use of proton pump inhibitors (PPIs). This study aimed to analyze the appropriateness of SUP prescribing patterns and identify its associated factors in the orthopedics department of a tertiary hospital in the Northwestern China. Methods: In this cross-sectional study, information regarding the demographic and clinical characteristics of 1,200 fracture inpatients who underwent surgical operations from January 2020 to August 2021 were collected from medical records. Established criteria were used to assess the appropriateness of the prescribing pattern for SUP, and the incidence of inappropriate SUP medication was calculated. Logistic regression analyses were used to identify factors associated with inappropriate SUP medication. Results: Approximately, 42.4% of the study population was interpreted as inappropriate prescription of SUP. A total of 397 (33.1%) patients received SUP without a proper indication (overprescription), and the incidence of inappropriate SUP medication was calculated to be 43.11 per 100 patient-days. In addition, 112 (9.3%) inpatients for whom SUP was indicated did not receive SUP (underprescription). PPIs were prescribed in 96.1% of the inpatients who used acid suppression therapy (AST), and intravenous PPIs accounted for 95.3% thereof. In a multivariate logistic regression analysis, age above 65 years and prolonged hospitalization were associated with overprescription of SUP. Increased number of drugs excluding PPIs, the concurrent use of systemic corticosteroids, comorbidity of hypertension, and unemployed or retired status in inpatients were associated with a reduced likelihood of overprescription for SUP. Conversely, prolonged hospitalization, the concurrent use of systemic corticosteroids or anticoagulants, and unemployed status in inpatients were positively associated with underprescription of SUP. Conclusion: There was a high prevalence of inappropriate SUP prescription among noncritically ill inpatients of fracture who underwent surgical operations. We delineated the associated factors with inappropriate SUP medication, which indicated that more information was required for clinicians about rationality and efficiency of their prescribing practices. Effective intervention strategies should be executed by clinical pharmacists to reduce improper SUP medication.

Keywords: clinical pharmacists; orthopedics department; proton pump inhibitors; stress ulcer prophylaxis; surgical inpatients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram demonstrating inpatient selection and subclassification. The selection and subclassification process for the inpatients who participated in the study is demonstrated. An initial sample size of 1,331 inpatients was selected randomly using a standard computer selection program, and 131 inpatients were excluded according to the criteria determined, and thus 1,200 inpatients were finally recruited in this study. The study inpatients were initially divided into subgroups on the basis of SUP prescription receivers or non–SUP prescription receivers, and then categorized into four groups through ascertaining if the indication was in accordance with the criteria determined. The inpatients who received SUP appropriately were subclassified into two groups according to the criteria determined, of which one met the criteria for SUP indication, while the other met the criteria for drug-induced ulcer prophylaxis.

References

    1. Afif W., Alsulaiman R., Martel M., Barkun A. N. (2007). Predictors of Inappropriate Utilization of Intravenous Proton Pump Inhibitors. Aliment. Pharmacol. Ther. 25 (5), 609–615. 10.1111/j.1365-2036.2006.03226.x - DOI - PubMed
    1. Allen M. E., Kopp B. J., Erstad B. L. (2004). Stress Ulcer Prophylaxis in the Postoperative Period. Am. J. Health Syst. Pharm. 61 (6), 588–596. 10.1093/ajhp/61.6.588 - DOI - PubMed
    1. Anderberg B., Sjödahl R. (1985). Prophylaxis and Management of Stress Ulcers. Scand. J. Gastroenterol. Suppl. 110, 101–104. 10.3109/00365528509095839 - DOI - PubMed
    1. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis (1999). ASHP Commission on Therapeutics and Approved by the ASHP Board of Directors on November 14, 1998. Am. J. Health Syst. Pharm. 56 (4), 347–379. 10.1093/ajhp/56.4.347 - DOI - PubMed
    1. Bardou M., Quenot J. P., Barkun A. (2015). Stress-related Mucosal Disease in the Critically Ill Patient. Nat. Rev. Gastroenterol. Hepatol. 12 (2), 98–107. 10.1038/nrgastro.2014.235 - DOI - PubMed

LinkOut - more resources